HUMAN UDP-GLUCURONOSYLTRANSFERASES SHOW ATYPICAL METABOLISM OF MYCOPHENOLIC ACID AND INHIBITION BY CURCUMIN
Authors:
- Labanyamoy KoleLKLabanyamoy Kole
- Shigeki KubotaSKShigeki Kubota
- Ida S. OwensIOIda S. Owens
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 32 (7) , 768-773
Abstract
Although the promising immunosuppressant, mycophenolic acid (MPA), has many desirable properties and is widely prescribed for organ transplant recipients, its high oral dosage requirement is not understood. Whereas previous Northern blot analysis by Basu and colleagues (2004) located the mRNAs encoding MPA primary metabolizers, UDP-glucuronosyltransferases (UGTs) 1A7, 1A8, 1A9, and 1A10, in human gastrointestinal (GI) tissues, in situ hybridization analysis of mRNAs found that the isozymes were restricted to the mucosal layer of various GI organs. Concomitantly, MPA was glucuronidated by microsomes isolated from normal adjoining specimens. Microsomal studies showed the highest relative rates of metabolism in esophagus, ileum, duodenum, colon, and stomach at pH 6.4; only esophagus showed high pH 7.6 activity. Properties of the recombinant UGTs indicate that MPA is metabolized with pH 6.4 or 7.6 optimum. Activity for 1A7 and 1A9 increased with increasing concentrations up to 2.4 mM, with parallel production of both ether- and acylglucuronides; similarly, 1A8 and 1A10 reached plateaus at 1.6 mM, producing both glucuronides. Km values were 250 to 550 μM. Between 400 and 1600 μM MPA, isozymes generated between 15 and 42% of the acylglucuronides. In effect, high Km values (MPA) are associated with high concentrations to achieve saturation kinetics. Finally, transient inhibition of UGTs in human LS180 colon cells and mouse duodenum by the dietary agent, curcumin, has implications for in vivo pretreatment to reduce MPA glucuronidation to increase the therapeutic index.Keywords
This publication has 24 references indexed in Scilit:
- Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltransferases Enhance Potential to Control Chemical UptakeJournal of Biological Chemistry, 2004
- Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activityBiochemical and Biophysical Research Communications, 2003
- Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by β-naphthoflavone in comparison with humansBiochemical Pharmacology, 2002
- Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locusPharmacogenetics, 2001
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesisCarcinogenesis, 2000
- Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38) by the Human UDP-Glucuronosyltransferases Encoded at the UGT1 LocusBiochemical and Biophysical Research Communications, 1999
- Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cellsBritish Journal of Pharmacology, 1998
- Altered Coding for a Strictly Conserved Di-glycine in the Major Bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar Type I PatientJournal of Biological Chemistry, 1995
- Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.Proceedings of the National Academy of Sciences, 1993